Valuation : Nanjing Well Pharmaceutical Group Co.,Ltd.

Market Cap 3.48B 519M 448M 421M 385M 720M 49.06B 721M 4.98B 1.93B 25.19B 1.95B 1.91B 81.11B P/E 2024
22.7x
P/E 2025 23.4x
Enterprise Value 3.63B 542M 467M 439M 401M 751M 51.18B 752M 5.19B 2.02B 26.28B 2.03B 1.99B 84.63B EV / Sales 2024
2.75x
EV / Sales 2025 2.75x
Free-Float
38.22%
Yield 2024
1.63%
Yield 2025 2.31%
08-21 Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 CI
06-15 Nanjing Well Pharmaceutical Group Co.,Ltd. signed a property rights transaction contract to acquire 50.98% stake in Lianyungang Wantai Pharmaceutical Excipients Technology Co., Ltd. from Tianjin Boguang Medical Biotechnology Development Co., Ltd. for CNY 19.4 million. CI
06-10 Nanjing Well Pharmaceutical Completes Updating Business Scope Registration MT
04-27 Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
04-27 Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
04-26 Nanjing Well Pharmaceutical Group Co.,Ltd. announces Annual dividend, payable on June 05, 2026 CI
25-10-29 Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2025 CI
25-08-19 Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2025 CI
25-04-21 Nanjing Well Pharmaceutical Group Co.,Ltd. announces Annual dividend, payable on June 13, 2025 CI
25-04-21 Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2025 CI
25-04-21 Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2024 CI
24-10-23 Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2024 CI
24-08-19 Nanjing Well Pharmaceutical Group Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2024 CI
1 day-1.87%
1 week-2.06%
Current month-2.17%
1 month+8.31%
3 months+0.35%
6 months-1.95%
Current year-1.27%
1 week 25.56
Extreme 25.56
26.98
1 month 23.83
Extreme 23.83
28.09
Current year 21.9
Extreme 21.9
28.9
1 year 21.9
Extreme 21.9
30.8
3 years 17.65
Extreme 17.65
33.34
5 years 17.65
Extreme 17.65
42.62
10 years 17.08
Extreme 17.08
42.62
Manager TitleAgeSince
Chief Executive Officer 63 2017-03-24
Director of Finance/CFO 59 2017-03-24
Chief Tech/Sci/R&D Officer 61 2017-03-24
Director TitleAgeSince
Chairman 63 2017-03-24
Director/Board Member 61 2017-03-24
Director/Board Member 57 2017-03-24
Date Insider Type Main position Quantity % Market Cap. Importance
6/4/20 Sell

Chairman

78,000 0.1307%
Change 5-day change 1-year change 3-year change Capi.($)
-1.87%-2.06%-9.57%-0.08% 528M
-1.69%+1.94%+42.50%+40.48% 667B
+1.50%+3.10%-3.69%+9.59% 186B
0.00%+4.71%+26.29%+7.77% 113B
+0.31%+6.98%+117.26%+166.44% 109B
+0.01%+6.96%+138.59%+177.53% 107B
+0.17%+6.37%+95.43%+117.71% 102B
+1.38%+2.35%+11.66%+4.36% 93B
-0.50%+1.14%+65.97%+100.52% 79.92B
-1.73%-2.86%+46.34%+125.85% 63.83B
Average -0.05%+2.85%+53.08%+75.02% 152.09B
Weighted average by Cap. +0.29%+3.60%+50.76%+62.57%

Financials

2024 2025
Net sales 1.3B 194M 167M 157M 143M 268M 18.28B 269M 1.85B 720M 9.39B 727M 711M 30.23B 1.34B 199M 172M 162M 148M 276M 18.82B 277M 1.91B 741M 9.67B 748M 732M 31.12B
Net income 146M 21.85M 18.85M 17.71M 16.18M 30.28M 2.06B 30.34M 209M 81.3M 1.06B 82.03M 80.25M 3.41B 151M 22.53M 19.43M 18.26M 16.69M 31.22M 2.13B 31.28M 216M 83.82M 1.09B 84.58M 82.74M 3.52B
Net Debt 234M 34.93M 30.13M 28.32M 25.87M 48.4M 3.3B 48.49M 335M 130M 1.69B 131M 128M 5.46B 151M 22.5M 19.41M 18.25M 16.67M 31.19M 2.13B 31.25M 216M 83.73M 1.09B 84.49M 82.66M 3.52B
Logo Nanjing Well Pharmaceutical Group Co.,Ltd.
Nanjing Well Pharmaceutical Group Co Ltd is a China-based company primarily engaged in the research, development, production, and sales of pharmaceutical excipients and synthetic lubricating base oils. The Company's products mainly include mechanical synthetic lubricating base oils, non-mechanical synthetic lubricating base oils, injectable pharmaceutical excipients, and non-injectable pharmaceutical excipients. The Company distributes its products within the domestic market and to overseas markets.
Employees
718
Date Price Change Volume
26-09-04 CN¥25.69 -1.87% 1,127,600
26-09-03 CN¥26.18 +0.04% 1,235,900
26-09-02 CN¥26.17 -1.65% 716,400
26-09-01 CN¥26.61 +1.33% 1,068,900
26-08-31 CN¥26.26 +0.73% 1,094,800
  1. Stock Market
  2. Stocks
  3. 603351 Stock